Alloy Review

What Is Alloy?

Alloy focuses on women's midlife health, offering GLP-1 weight management alongside hormone therapy and other treatments. Their board-certified doctors specialize in menopause and midlife health, with care beginning in as little as 12 business hours. With 24/7 messaging access and transparent cash-pay pricing (FSA/HSA accepted), Alloy reports members achieving 20% average body weight loss over 12 months.

How Does Alloy Work?

Here's what the process actually looks like with Alloy, step by step:

1. 1
   Online intake: Assessment covering menopausal status, weight history, and overall health.
2. 2
   Care within 12 hours: Alloy commits to starting care within twelve hours, which is the fastest in the category.
3. 3
   Specialist review: A menopause-trained clinician evaluates whether GLP-1 therapy, hormone therapy, or both are appropriate.
4. 4
   Free shipping: Medication ships at no additional charge.
5. 5
   24/7 doctor messaging: Ongoing access to physicians rather than a support queue.

Twelve-hour care start is a real differentiator

The gap between deciding to pursue treatment and actually starting is where a lot of patients drop out. Two weeks of waiting for an appointment is enough time for motivation to fade and for competing priorities to reassert themselves.

Alloy commits to starting care within twelve hours. For a specialty practice that's remarkable — the usual alternative for menopause care is a multi-month wait.

24/7 doctor messaging extends the same principle into ongoing care. Note the distinction: doctor messaging, not support-agent messaging. The person answering can make a clinical decision.

The 20% weight loss figure, in context

Alloy cites 20% average body weight loss over twelve months. That's at the upper end of what GLP-1 therapy achieves — tirzepatide's SURMOUNT-1 trial produced roughly 20.9% at the highest dose over 72 weeks.

Two things are worth noting. First, program-reported averages describe patients who stayed enrolled, which selects for responders. Second, Alloy offers brand-name Zepbound, so the underlying pharmacology genuinely supports figures in that range.

Treat it as a plausible upper-range outcome for an engaged patient on tirzepatide rather than an expected value.

Cash-pay with FSA/HSA is better than it looks

Alloy is cash-pay, which puts it at an apparent disadvantage against Midi's insurance model. FSA/HSA eligibility narrows that gap more than most patients realize.

At a 24% marginal federal rate plus state tax, paying with pre-tax dollars is roughly a 25–35% discount. A $300 monthly program costs about $200–$225 in after-tax income.

If you have an FSA with a use-it-or-lose-it deadline, this is one of the better places to direct it. Worth planning during open enrollment rather than discovering in December.

Brand-name access and its cost consequence

Alloy offers Zepbound and Wegovy — actual FDA-approved products. That's a meaningful safety and predictability advantage over compounded programs.

It also means the price floor is set by Eli Lilly and Novo Nordisk. Alloy cannot be a $199-a-month program while dispensing brand-name tirzepatide, and comparing it to compounded providers on price is comparing different products.

Published pricing is thinner than we'd like. Get your maintenance-dose figure in writing before enrolling.

Treatment Options

Alloy Pricing

Click here for best pricing

Alloy runs two tracks. Compounded tirzepatide is $100 a month for the medication plus a $99 monthly fee — about $199 all-in, which is competitive. Brand-name Zepbound and Wegovy are also available but set the price floor at manufacturer levels. Published pricing across the brand-name track is thin, so get a written quote. FSA/HSA eligibility is the most underused lever here either way.

Pricing may vary based on your specific treatment plan and medication selection. Contact Alloy directly for the most current pricing information.

Who Should Use Alloy?

Women in midlife seeking fast access to GLP-1s with expert support

• Midlife women who want to start treatment immediately rather than wait weeks
• Anyone who wants brand-name FDA-approved medication with menopause expertise
• Patients with FSA or HSA funds to deploy
• People who value direct physician messaging around the clock

Who Is Alloy Not For?

• Patients with insurance that would cover GLP-1s — use the coverage
• Anyone outside the midlife women's demographic
• Cost-sensitive patients who'd do better with a compounded program
• Anyone who is pregnant, planning pregnancy, or breastfeeding
• People with a personal or family history of medullary thyroid carcinoma or MEN2, or a history of pancreatitis — discuss these with your doctor

Alloy — Frequently Asked Questions

How Alloy Compares

If Alloy isn't the right fit, these are the alternatives we'd point you to first — and why.